gp100 (87-95)

gp100 (87-95) is a synthetic peptide corresponding to amino acids 87 through 95 of the human glycoprotein 100 (gp100), a melanocyte differentiation antigen extensively studied in the context of melanoma and immunological research. As a defined peptide fragment, it serves as a valuable tool for dissecting antigen-specific immune responses, notably in studies involving T cell recognition and peptide-MHC interactions. Its precise sequence and immunological relevance make it a cornerstone in the investigation of tumor-associated antigens, antigen processing, and presentation pathways, as well as in the development of peptide-based immunological assays.

Antigen Presentation Studies: Researchers utilize gp100 (87-95) to investigate the mechanisms of antigen processing and presentation via the major histocompatibility complex (MHC) class I pathway. By pulsing antigen-presenting cells with this peptide, it is possible to analyze the efficiency and specificity of peptide loading onto MHC molecules, supporting fundamental studies on immune recognition and cellular immunology. Such experiments help elucidate how tumor-associated antigens are displayed to cytotoxic T lymphocytes, informing both basic and translational immunology.

T Cell Activation Assays: The peptide is widely employed in functional assays designed to assess the activation, specificity, and cytotoxic potential of T cells recognizing the gp100 epitope. In vitro systems incorporating this fragment enable the measurement of cytokine production, proliferation, and cytolytic activity of antigen-specific T cell populations. These applications are critical for characterizing immune responses, validating T cell receptor (TCR) specificity, and optimizing adoptive cell transfer protocols in preclinical research.

Peptide-MHC Tetramer Generation: gp100 (87-95) serves as an essential component in the synthesis of peptide-MHC tetramers, which are powerful reagents for the detection and quantification of antigen-specific T cells by flow cytometry. Incorporating this peptide into tetramer complexes allows for the precise identification and enumeration of T cells targeting the gp100 epitope, supporting detailed immunophenotyping and monitoring of immune responses in experimental settings.

Epitope Mapping and Immunogenicity Profiling: The defined sequence of gp100 (87-95) makes it an ideal probe for mapping T cell epitopes and evaluating the immunogenic potential of tumor-associated antigens. Through systematic analysis using this peptide, researchers can delineate the minimal recognition motifs required for T cell activation, compare immunodominant regions across different antigens, and assess cross-reactivity with related peptide sequences. These studies contribute to the rational design of immunological assays and antigen-specific reagents.

Peptide-Based Vaccine Research: In the context of experimental immunization studies, gp100 (87-95) is frequently incorporated into peptide-based vaccine formulations to evaluate its capacity to elicit antigen-specific immune responses in vitro and in preclinical models. By examining the immunogenicity and functional consequences of vaccination with this fragment, investigators gain insights into the principles of antigen selection, adjuvant optimization, and the induction of robust cellular immunity against melanoma-associated antigens. Such research underpins the development of next-generation immunotherapeutic strategies and informs the broader field of cancer immunology.

1. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry